Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges

Matteo Olivi(University of Turin), Marco Cerrano(Assistance Publique – Hôpitaux de Paris), Dario Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Eloise Beggiato, Vincenzo Apolito(University of Turin), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Giuseppe Lanzarone(University of Turin), Federica Martella(Fatebenefratelli Hospital), Carolina Secreto(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Giulia Arrigo(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Federica Di Biase(University of Turin), Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Roberto Freilone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Current Treatment Options in Oncology
April 26, 2023
10.1007/s11864-023-01089-w
Cited by 20

Related Papers

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
|Blood|2003|407
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
|JAMA|2011|320
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
|Blood|2011|268
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma
|Biology of Blood and Marrow Transplantation|2008|264
Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation
|Journal of Clinical Oncology|2013|212